CtIP Antibodies

Santa Cruz Biotechnology provides a broad selection of CtIP Antibodies for studying DNA repair and cellular response to DNA damage. CtIP Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CtIP, or C-terminal binding protein interacting protein, plays a crucial role in the homologous recombination repair pathway by facilitating the repair of double-strand breaks in DNA. The function of CtIP is essential for maintaining genomic stability and preventing tumorigenesis, making it a significant focus in cancer research. Investigating CtIP activity provides valuable insights into DNA damage response mechanisms and potential therapeutic approaches. Researchers worldwide rely on CtIP monoclonal antibodies to explore DNA repair pathways and their implications in various diseases. Understanding CtIP behavior and regulation continues to reveal new possibilities in cancer treatment strategies. The high specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to DNA repair and cancer biology research.